Citius Oncology, Inc.

CTOR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Sep 23, 2025 OWNERSHIP DOCUMENT
4 Sep 23, 2025 OWNERSHIP DOCUMENT
4 Sep 23, 2025 OWNERSHIP DOCUMENT
4 Sep 23, 2025 OWNERSHIP DOCUMENT
4 Sep 23, 2025
4 Sep 23, 2025 OWNERSHIP DOCUMENT
4 Sep 23, 2025 OWNERSEHIP DOCUMENT
4 Sep 23, 2025 OWNERSHIP DOCUMENT
4 Sep 23, 2025 OWNERSHIP DOCUMENT
4 Sep 23, 2025 OWNERSHIP DOCUMENT
S-8 Sep 19, 2025 REGISTRATION STATEMENT
8-K Sep 19, 2025 CURRENT REPORT
SCHEDULE 13D/A Sep 12, 2025
424B3 Sep 10, 2025 PROSPECTUS
8-K Sep 10, 2025 CURRENT REPORT
424B5 Sep 10, 2025 PROSPECTUS SUPPLEMENT
EFFECT Sep 4, 2025
CORRESP Sep 2, 2025
S-3 Sep 2, 2025 REGISTRATION STATEMENT
UPLOAD Aug 22, 2025
DRS Aug 20, 2025
8-K Aug 18, 2025 CURRENT REPORT
424B3 Aug 18, 2025 PROSPECTUS SUPPLEMENT
8-K Aug 12, 2025 CURRENT REPORT
10-Q Aug 12, 2025 QUARTERLY REPORT
← Newer Page 4 of 11 · 267 filings Older →